{"id":"W2947055368","doi":"10.1200/jco.2019.37.15_suppl.10009","title":"Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; ROS1; Response Evaluation Criteria in Solid Tumors; Internal medicine; Crizotinib; Refractory (planetary science); ALK inhibitor; Anaplastic lymphoma kinase; Oncology; Progressive disease; Cancer; Disease; Adenocarcinoma; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002113397,0.0001785687,0.001632266,0.0001908637,0.00004008738,0.0000135233,0.0001951643,0.0001431545,0.00001724401],"category_scores_gemma":[0.001904505,0.00009025472,0.0002021453,0.0002209576,0.0001265227,0.0001236465,0.0001202612,0.001263161,0.000005974847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003158353,"about_ca_system_score_gemma":0.001642332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004431578,"about_ca_topic_score_gemma":0.00006849493,"domain_scores_codex":[0.996132,0.001067982,0.001533314,0.0002674805,0.0005914971,0.0004076902],"domain_scores_gemma":[0.9963849,0.001185435,0.001436016,0.0002248209,0.0001964757,0.000572321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5596575,0.01922028,0.2979755,0.0001612321,0.0004278639,0.001621835,0.0001523879,0.000009349488,0.0009559818,0.000004669697,0.0001501206,0.1196633],"study_design_scores_gemma":[0.1751868,0.09637174,0.7245962,0.001513429,0.0001706365,0.00111377,0.0001499512,0.00006598055,0.0006141098,0.000001893932,0.0001290234,0.0000864264],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973788,0.00003925554,0.00001037159,0.0005549844,0.0006073599,0.00127148,0.000008004736,0.000006725553,0.0001229839],"genre_scores_gemma":[0.9991349,0.00007220158,0.00009323248,0.0001294293,0.00051491,0.000006969238,0.000001040426,0.00001831221,0.00002901909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4266207,"threshold_uncertainty_score":0.5487875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.137663748049191,"score_gpt":0.4875379488064219,"score_spread":0.3498742007572309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}